| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2128694A1 Process for producing plasminogen-containing composition |
| 06/08/1994 | EP0600717A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis |
| 06/08/1994 | EP0434807B1 Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis |
| 06/07/1994 | US5319072 Human antithrombin-III preparation |
| 06/07/1994 | US5318968 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones |
| 06/07/1994 | US5318899 Platelet aggregation inhibitors |
| 06/07/1994 | US5318524 Fibrin sealant delivery kit |
| 06/07/1994 | CA1330036C Inhibition of arterial thrombotic occlusion or thromboembolism |
| 06/03/1994 | CA2110464A1 Guanidinyl-substituted heterocyclic thrombin inhibitors |
| 06/01/1994 | EP0598770A1 New pyrazine derivatives, their preparation and their use. |
| 06/01/1994 | EP0484437A4 Renal-selective prodrugs for the treatment of hypertension |
| 06/01/1994 | CN1087337A Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives |
| 06/01/1994 | CN1024801C Process for preparing beta-D-phenyl-thioxylosides |
| 05/31/1994 | US5316947 Synthetic isohirudins with improved stability |
| 05/31/1994 | US5316766 Thrombosis treatment with fibrinolytics and prostacyclins |
| 05/31/1994 | CA2110251A1 Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis |
| 05/31/1994 | CA1329932C Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/26/1994 | WO1994011399A1 Specifically crosslinked hemoglobin with free functionality |
| 05/26/1994 | WO1994011398A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011370A1 Substituted amino alkyl compounds |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011022A1 Use of topically applied factor xiii for inhibiting hemorrhage |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011007A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | WO1994011000A1 Xanthine derivatives for use as diuretics |
| 05/26/1994 | WO1994010990A1 Inhibition of tnf production |
| 05/26/1994 | CA2149132A1 Specifically crosslinked hemoglobin with free functionality |
| 05/26/1994 | CA2149046A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | CA2148945A1 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein iib/iiia |
| 05/26/1994 | CA2148473A1 Xanthine derivatives for use as diuretics |
| 05/25/1994 | EP0598474A1 2-Deoxy-2-amino hexuronyl derivatives of heparin and a method for production |
| 05/25/1994 | EP0434833B1 9-fluor-prostaglandine derivates, their process of production and their pharmaceutical use |
| 05/25/1994 | CN1087084A New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloa lkylacetamides |
| 05/25/1994 | CN1087080A Benzenealkanoic acids for cardiovascular diseases |
| 05/25/1994 | CN1087015A Preparing of pharmaceutical with activity of resolution of thrombus by use of agent directly inhibiting thrombin |
| 05/24/1994 | US5314883 Vasodilation, anticoagulants |
| 05/24/1994 | US5314880 Benzimidazole derivatives |
| 05/24/1994 | US5314876 High molecular mass N,O-sulphated heparosans, process for their preparation and the pharmaceutical compositions which contain them |
| 05/24/1994 | US5314818 Human tissue plasminogen activator variants |
| 05/24/1994 | US5314695 Tissue factor based prothrombin time reagent |
| 05/24/1994 | CA1329762C Potentiation of erythropoiesis |
| 05/19/1994 | DE4238367A1 Diuretisches Mittel Diuretic agents |
| 05/18/1994 | EP0597503A2 ECK receptor ligands |
| 05/18/1994 | EP0597291A1 2,3-diphenyl-5-pyrrolyl-furan derivatives, processes and intermediates for their preparation and their use as anti-inflammatory, and anti-allergic and platelet aggregation inhibiting agents |
| 05/18/1994 | EP0502872B1 Methods and materials for expression of human plasminogen variant |
| 05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |
| 05/18/1994 | CN1086825A The present invention is concerned with tri- and tetracyclic compounds |
| 05/18/1994 | CN1086813A 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for TH |
| 05/17/1994 | US5312812 Pharmaceutical compositions comprising novel oligopeptides exhibiting selective inhibiting effect upon the proliferation of hemopoietic cells |
| 05/17/1994 | US5312809 Physiologically active substance derived from malt and process for the production thereof |
| 05/17/1994 | US5312808 Polyoxyethylene glycol conjugates with hemoglobin |
| 05/17/1994 | US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog |
| 05/17/1994 | CA1329600C 1,4-dihydropyridines |
| 05/17/1994 | CA1329591C Pharmaceutical products and new lactosyl compounds and the preparation thereof |
| 05/17/1994 | CA1329542C Plasma and recombinant protein formulations in low ionic strength media |
| 05/11/1994 | WO1994010318A1 Thrombin activatable plasminogen derivatives |
| 05/11/1994 | WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 05/11/1994 | WO1994010142A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/11/1994 | WO1994009784A1 Platelet aggregation inhibitor |
| 05/11/1994 | WO1994009625A2 Stabilization of fluorocarbon emulsions |
| 05/11/1994 | EP0596350A1 Cyclopeptides |
| 05/11/1994 | EP0595924A1 Platelet activating factor antagonists |
| 05/11/1994 | EP0463162B1 PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES |
| 05/10/1994 | US5310551 Method for inhibiting pulmonary oxygen toxicity |
| 05/10/1994 | US5310550 Platelet deficiency |
| 05/10/1994 | CA1329391C Pyrrolidine derivatives |
| 05/04/1994 | EP0595557A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/04/1994 | EP0594999A1 Phospholipid derivatives containing higher elements of the fifth main group |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594725A1 Yolk sac stem cells |
| 05/04/1994 | EP0594667A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 05/04/1994 | EP0515456B1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them |
| 05/04/1994 | EP0434832B1 D8- and D9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE |
| 05/04/1994 | CN1086221A Peptide compounds |
| 05/03/1994 | US5308850 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | CA1329209C 2-amino-tetrahydro-isoquinoline derivatives and a process for the preparation thereof and pharmaceutical compositions containing same |
| 05/03/1994 | CA1329205C Tetrahydrofuran derivatives |
| 05/03/1994 | CA1329199C Method of treating cachexia and certain new compounds for use in this method |
| 04/28/1994 | WO1994009027A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | WO1994009014A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors |
| 04/28/1994 | WO1994008962A1 Fibrinogen receptor antagonists |
| 04/28/1994 | WO1994008941A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | WO1994008577A1 Fibrinogen receptor antagonists |
| 04/28/1994 | CA2146869A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | CA2146446A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | CA2144763A1 Fibrinogen receptor antagonists |
| 04/28/1994 | CA2144762A1 Fibrinogen receptor antagonists |
| 04/27/1994 | EP0593633A1 Metabolizable plasma substitute |
| 04/27/1994 | EP0593603A1 Bicyclic fibrinogen antagonists |
| 04/27/1994 | EP0455725B1 Pharmaceutical formulations of plasminogen activator proteins |
| 04/27/1994 | CN1085912A Peptide compounds |
| 04/27/1994 | CN1085911A Peptide compounds |
| 04/27/1994 | CN1085894A Antiinflammatory indolinyl N-hydroxyurea and N-hydroxamic acid derivatives |
| 04/26/1994 | US5306508 Red blood cell surrogate |
| 04/26/1994 | CA1328873C Hypoglycemic thiazolidinedione derivatives |
| 04/26/1994 | CA1328871C Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |